Novo Nordisk, Lilly Sued Over Stomach Paralysis Allegations Regarding GLP-1 Drugs

A Louisiana woman has filed a lawsuit alleging that Novo Nordisk’s Ozempic and Eli Lilly’s Mounjaro did not have warnings about the risk of severe gastrointestinal problems.

Scroll to Top